According to IMARC Group’s latest report, titled “Asthma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global asthma therapeutics market size reached US$ 17.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 20.1 Billion by 2027, exhibiting a growth rate (CAGR) of 2.13% during 2022-2027.
Asthma, or bronchial asthma, is a chronic condition that affects the lungs and is typically triggered by indoor and outdoor causative agents, such as allergens, pollution, and dust. Depending on the cause and severity of the symptoms, the condition is differentiated into two types, namely intermittent and persistent asthma. Asthma therapeutics include various pharmaceutical drugs that are used to treat the ailment. Corticosteroids, long-acting beta-agonists (LABA), methylxanthine, immunomodulators, and leukotriene modifiers are some asthma therapeutics available in the market. These drugs enable the movement of air by expanding the passageway into the lungs, thus considerably improving breathing. Several combination therapy drugs are also available that can be injected, orally administered, or inhaled.
Request a Free PDF Sample of the Report: https://www.imarcgroup.com/asthma-therapeutics-market/requestsample
Market Trends and Drivers:
The primary factor accelerating the global asthma therapeutics market includes the rising incidences of respiratory diseases and the growing demand for cost-effective treatment options. Moreover, the increasing consumer awareness regarding the availability of effective asthma therapeutics and the surging demand for monoclonal antibodies (mAbs) are providing an impetus to the market growth. In line with this, key market players are developing combination therapies to enhance the treatment of respiratory diseases, which, in turn, is boosting the market growth. Apart from this, the growing healthcare expenditures and rising research and development (R&D) activities are factors creating a positive outlook for the market.
Asthma Therapeutics Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the asthma therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- AstraZeneca PLC
- Abbott Laboratories
- Amgen Inc.
- Biogen Inc.
- Boehringer Ingelheim International GmbH
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Merck Sharp & Dohme Corp.
- Novartis International AG
- Sunovion Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
Key Market Segmentation:
The report has segmented the global asthma therapeutics market based on drug class, product type, treatment type, route of administration and region.
Breakup by Drug Class:
- Anti-Inflammatory Drugs
- Bronchodilators
- Combination Therapies
Breakup by Product Type:
- InhalersDry Powder Inhalers
Metered Dose Inhalers
Soft Mist Inhalers
- NebulizersPneumatic Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers
Breakup by Treatment Type:
- Quick-Relief Medications
- Long-Term Asthma Control Medications
Breakup by Route of Administration:
- Inhalation
- Oral
- Parenteral
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/asthma-therapeutics-market
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800